Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-03-02
1999-10-19
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514307, 546143, 546144, A01N 4342
Patent
active
059689501
ABSTRACT:
A hydrochloride salt of an Apo B secretion/MTP inhibitor, methods of making the salt, methods of using the salt and pharmaceutical compositions containing the salt are disclosed.
REFERENCES:
patent: 4022900 (1977-05-01), Mathison
Wetterau, John R. et al., "Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues" Biochimica et Biophysica Acta, 875, 1986, pp. 610-617.
Wetterau, John R. et al, "Absence of Microsomal Triglyceride Transfer Protein in Individuals with Abetalipoproteinemia" Science, vol. 258, Nov. 6, 1992, pp. 999-1001.
Chang George
Quallich George J.
Wint Lewin T.
Benson Gregg C.
Jones Dwayne C.
Olson A. Dean
Pfizer Inc
Richardson Peter C.
LandOfFree
Apo B-secretion/MTP inhibitor hydrochloride salt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apo B-secretion/MTP inhibitor hydrochloride salt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apo B-secretion/MTP inhibitor hydrochloride salt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2055776